IOVANCE BIOTHERAPEUTICS, INC. 8-K

Accession 0001104659-21-035027

Filing information

CIK: 0001425205
Report date: 2021-03-05
Filing date: 2021-03-11
Form: 8-K
Primary document: tm219261d1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.